Effect of tamsulosin on reducing discomfort caused by ureteral stenting
Phase 2
- Conditions
- Discomfort after ureteral stenting in patients with urolithiasis.Calculus of kidney and ureter
- Registration Number
- IRCT2015042221886N2
- Lead Sponsor
- Exir Pharmaceutical Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
age equal to 18 and more; urolithiasis indicated for transurethral litotripsy and Double J ureteral stenting thereafter.
Exclusion criteria: significant ureteral trauma; presence of previous ureteral stent; other concurrent operations; previous prostate resection; bladder tumors; urinary infections; history of chronic pain; pregnancy; age less than 18; prostate cancer; cardiovascular disease, coronary artery disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain interference with sleep. Timepoint: day 14 of intervention. Method of measurement: questionnaire.;Pain interference with daily activity. Timepoint: day 14 of intervention. Method of measurement: questionnaire.;Frequency of urination. Timepoint: day 14 of intervention. Method of measurement: questionnaire.;Flank pain. Timepoint: day 14 of intervention. Method of measurement: questionnaire.;Severity of pain during urination. Timepoint: day 14 of intervention. Method of measurement: questionnaire.;Painkiller consumption. Timepoint: day 14 of intervention. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method